These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
977 related articles for article (PubMed ID: 28193203)
1. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
2. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160 [TBL] [Abstract][Full Text] [Related]
6. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131 [TBL] [Abstract][Full Text] [Related]
8. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas. Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381 [TBL] [Abstract][Full Text] [Related]
9. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144 [TBL] [Abstract][Full Text] [Related]
10. High-grade meningiomas: biology and implications. Bi WL; Prabhu VC; Dunn IF Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053 [TBL] [Abstract][Full Text] [Related]
11. Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas. Pemov A; Dewan R; Hansen NF; Chandrasekharappa SC; Ray-Chaudhury A; Jones K; Luo W; Heiss JD; Mullikin JC; Chittiboina P; Stewart DR; Asthagiri AR Sci Rep; 2020 Jul; 10(1):12563. PubMed ID: 32724039 [TBL] [Abstract][Full Text] [Related]
12. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450 [TBL] [Abstract][Full Text] [Related]
14. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients. Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M J Neurosurg; 2021 May; 134(5):1377-1385. PubMed ID: 32442973 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal instability in meningiomas. van Tilborg AA; Al Allak B; Velthuizen SC; de Vries A; Kros JM; Avezaat CJ; de Klein A; Beverloo HB; Zwarthoff EC J Neuropathol Exp Neurol; 2005 Apr; 64(4):312-22. PubMed ID: 15835267 [TBL] [Abstract][Full Text] [Related]
16. Genomic profile of human meningioma cell lines. Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950 [TBL] [Abstract][Full Text] [Related]
17. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002 [TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of synchronous intracranial meningiomas with different histological grades. Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538 [TBL] [Abstract][Full Text] [Related]
19. NF2 mutations in secretory and other rare variants of meningiomas. Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978 [TBL] [Abstract][Full Text] [Related]
20. Whole Exome Sequencing of Multiple Atypical Meningiomas in a Patient without History of Neurofibromatosis Type II: A Case Report. Lyu J; Quan Y; Wang JB; Gong SP Am J Case Rep; 2020 May; 21():e923928. PubMed ID: 32461543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]